Cargando…

Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early-stage pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, and early diagnosis and assessment may enhance the quality of life and survival of patients. The prognostic value of key family 2 cystatins subunit in PDAC patients remains unknown. The potential molecular roles of famil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chengkun, Yu, Tingdong, Liu, Zhengqian, Ye, Xinping, Liao, Xiwen, Wang, Xiangkun, Han, Chuangye, Zhu, Guangzhi, Qin, Wei, Peng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549077/ https://www.ncbi.nlm.nih.gov/pubmed/31059105 http://dx.doi.org/10.3892/or.2019.7135

Ejemplares similares

Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018)

Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus-related hepatocellular carcinoma
por: Zhou, Xin, et al.
Publicado: (2019)

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018)

Prognostic value of Kinesin‐4 family genes mRNA expression in early‐stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
por: Han, Quanfa, et al.
Publicado: (2019)

Clinical significance and prospective molecular mechanism of C-C motif chemokine receptors in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Zhou, Xin, et al.
Publicado: (2019)

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2017)

Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms
por: Zhou, Xin, et al.
Publicado: (2019)

Comprehensive analysis of LILR family genes expression and tumour‐infiltrating immune cells in early‐stage pancreatic ductal adenocarcinoma
por: Gao, Qiang, et al.
Publicado: (2023)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2021)

Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma
por: Chen, Zijun, et al.
Publicado: (2021)

Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma
por: Komura, Takuya, et al.
Publicado: (2017)

Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus-associated hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Identification of prognostic biomarkers for patients withhepatocellular carcinoma after hepatectomy
por: Wang, Xiangkun, et al.
Publicado: (2019)

Genome-wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein-coding genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2018)

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus-related hepatocellular carcinoma
por: Han, Quanfa, et al.
Publicado: (2019)

Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
por: Yang, Chengkun, et al.
Publicado: (2018)

Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2018)

NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2017)

Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China
por: Qin, Wei, et al.
Publicado: (2020)

Cystatins in Immune System
por: Magister, Špela, et al.
Publicado: (2012)

Cystatins in Health and Diseases
por: Shah, Aaliya, et al.
Publicado: (2008)

PROTEINASE INHIBITORS | Cystatins
por: Pemberton, P.A.
Publicado: (2006)

Cystatin F is a biomarker of prion pathogenesis in mice
por: Nuvolone, Mario, et al.
Publicado: (2017)

Cystatin F Affects Natural Killer Cell Cytotoxicity
por: Perišić Nanut, Milica, et al.
Publicado: (2017)

Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity
por: Kim, J-T, et al.
Publicado: (2013)

Genetic variants and Expression of Cytochrome p450 Oxidoreductase Predict Postoperative Survival in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Huang, Ketuan, et al.
Publicado: (2019)

Cystatin C and Cystatin SN As Possible Soluble Tumor Markers in Malignant Uveal Melanoma
por: Dikovskaya, Maria A., et al.
Publicado: (2021)

Intraoperative Indocyanine Green Retention Test of Left Hemiliver in Decision-Making for Patients With Hepatocellular Carcinoma Undergoing Right Hepatectomy
por: Yu, Tingdong, et al.
Publicado: (2021)

Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Cystatin F Ensures Eosinophil Survival by Regulating Granule Biogenesis
por: Matthews, Stephen P., et al.
Publicado: (2016)

Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity
por: Prunk, Mateja, et al.
Publicado: (2020)

Cystatin C in Alzheimer's disease
por: Kaur, Gurjinder, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0pk5rdkoakrc00gr7js0aeagvq